---
title: "Praxis Precision Medicines grants 7,318 RSUs to 29 new employees under 2024 inducement plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294862721.md"
description: "Praxis Precision Medicines granted 7,318 restricted stock units (RSUs) to 29 new non-executive employees on August 3, 2026. The awards were issued under the company’s 2024 Inducement Plan and vest in four equal annual installments, contingent upon continued employment."
datetime: "2026-08-04T20:02:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294862721.md)
  - [en](https://longbridge.com/en/news/294862721.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294862721.md)
---

# Praxis Precision Medicines grants 7,318 RSUs to 29 new employees under 2024 inducement plan

-   Praxis Precision Medicines granted restricted stock units covering 7,318 common shares to 29 new non-executive employees on Aug. 3, 2026. \* Awards were issued under the company’s 2024 Inducement Plan. \* Restricted stock units vest in four equal annual installments, subject to continued employment on each vesting date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Praxis Precision Medicines Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608041601PRIMZONEFULLFEED9803442) on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)

## Related News & Research

- [Praxis Precision Medicines (PRAX) Wins FDA Breakthrough Tag As CNS Pipeline Advances](https://longbridge.com/en/news/295313402.md)
- [Praxis Q2 2026 results: $1.4 billion liquidity supports runway into 2028](https://longbridge.com/en/news/295110125.md)
- [Xylem sets quarterly distribution at R$ 0.75 per unit for 3Q 2026](https://longbridge.com/en/news/296117630.md)
- [Investors House to release H1 2026 results](https://longbridge.com/en/news/295920631.md)
- [Nordhealth announces H1 2026 interim financial report availability](https://longbridge.com/en/news/296180225.md)